Invokana Lawsuit

If you or a loved one have suffered serious side effects such as heart attack, stroke, amputation, kidney disease, kidney failure or diabetic ketoacidosis after taking Invokana, Invokamet, Farxiga, Xigduo XR, Glyxambi or Jardiance, compensation may be available from the drug manufacturer through a legal claim.  It’s free to find out if you qualify and costs nothing out-of-pocket to get started. No attorney fees unless we win your claim.

Do not delay. Damages may include medical expenses, wage loss, pain and suffering, loss of enjoyment of life and loss of consortium.

What Is This Lawsuit About?

Lawsuits allege that Janssen / Johnson & Johnson, manufacturer of Invokana, a popular Type Two Diabetes drug failed to warn both the medical community and consumers of serious potential side effects including heart attacks, kidney disease, and ketoacidosis.  

Ketoacidosis is a serious condition, usually requiring hospitalization due to the possibility of fatal brain swelling, coma, and severe dehydration. It’s further been alleged that had the public been properly warned, doctors and patients may have chosen something other than Invokana for diabetes management or at the very least, monitored for health issues more frequently.

Lawsuit Accuses Johnson & Johnson, Janssen Pharmaceuticals of Failure to Adequately Research Invokana and Failure to Warn of Health Risks

In a lawsuit filed on July 3, 2017, plaintiff Martha Williams of Tennessee accuses Janssen Pharmaceuticals and parent company Johnson & Johnson of failing to adequately research all potential health risks of its new generation diabetes drug Invokana as well as failure to warn the public and medical community of such risks. The lawsuit blames an onset of acute renal failure, a urinary tract infection, dehydration, and hypokalemia suffered by Williams just one month after starting the medication.

“Consumers of Invokana and their physicians relied on the Defendants’ false representations and were misled as to the drug’s safety, and as a result have suffered injuries including diabetic ketoacidosis, kidney failure, sepsis, cardiovascular problems, stroke, and the life-threatening complications thereof,” the lawsuit states. “The development of Plaintiff’s injuries was preventable and resulted directly from Defendants’ failure and refusal to conduct proper safety studies, failure to properly assess and publicize alarming safety signals, suppression of information revealing serious and life-threatening risks, willful and wanton failure to provide adequate instructions, and willful misrepresentations concerning the nature and safety of Invokana.”

We are available 24/7, waiting to assist.
Call:  800-530-9800.


Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.

Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.

Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.

Read more about our attorneys here.


CALL 24/7:  800-530-9800